Innovative ETFs Content Hub Biotech ETFs Strengthen After Judge Blocks Trump’s Drug Pricing Rule By Max ChenJuly 9, 2019
Alternatives Content Hub Sector ETFs Most at Risk of Earning Disappointments Ahead By Max ChenJuly 2, 2019
Innovative ETFs Content Hub AbbVie, Allergan Deal Puts Spotlight on Pharmaceutical ETFs By Max ChenJune 25, 2019
Disruptive Technology Content Hub 4 ARK ETFs to Help Investors Access Innovative Disruptors By Max ChenJune 21, 2019
Innovative ETFs Content Hub Biotech ETFs Are Breaking Out on Pfizer’s Array Biopharma Deal By Max ChenJune 17, 2019
Innovative ETFs Content Hub Look to Healthcare ETFs for Stability in a Shaky Market By Max ChenMay 10, 2019
Multifactor Content Hub Investing for Tomorrow, Today: Exploring the Future of Health Care By Max ChenApril 28, 2019
Relative Value Content Hub 12 Biggest Healthcare ETFs Ready for Sector Rebound By Tom LydonApril 24, 2019
Relative Value Content Hub U.S.-Based Activists Are Expanding, Everywhere Except The U.S. By ValueWalkApril 22, 2019
Relative Value Content Hub Jeffrey Williams Ubben: Is Active Management Dead? By ValueWalkApril 19, 2019
Innovative ETFs Content Hub Healthcare, Biotech ETFs Plunge on Mounting Political Pressures By Max ChenApril 18, 2019
Relative Value Content Hub UnitedHealth Drops 5% Today and Hits 52-Week Low By ETF TrendsApril 18, 2019
